Log in
Enquire now
‌

US Patent 11040034 Metalloenzyme inhibitor compounds

Patent 11040034 was granted and assigned to Phasebio Pharmaceuticals, Inc. on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Phasebio Pharmaceuticals, Inc.
0
Current Assignee
‌
Phasebio Pharmaceuticals, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110400340
Patent Inventor Names
Sammy R. Shaver0
Christopher M. Yates0
Steven Sparks0
William J. Hoekstra0
Date of Patent
June 22, 2021
0
Patent Application Number
161248460
Date Filed
September 7, 2018
0
Patent Citations
‌
US Patent 10538511 Metalloenzyme inhibitor compounds
Patent Citations Received
‌
US Patent 11919883 Metalloenzyme inhibitor compounds
0
Patent Primary Examiner
‌
Emily A Bernhardt
0
Patent abstract

Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11040034 Metalloenzyme inhibitor compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.